3 results match your criteria: "The Pelvic Solutions Center[Affiliation]"
Do we need more patient-friendly treatment options for overactive bladder (OAB)?
Neurourol Urodyn
August 2021
Avation Medical Inc, Columbus, Ohio, USA.
Aims: To collect feedback from subjects diagnosed with overactive bladder (OAB) on its impact on their quality of life, their satisfaction with current treatment options, and to assess nonsurgical, tibial nerve stimulation as a treatment option.
Methods: Subjects were asked a variety of questions about the impact of OAB on their lives, their satisfaction with current and previous treatment approaches. Subjects evaluated the comfort of a nonworking prototype garment and were given electrical stimulation over their posterior tibial nerve to assess comfort and tolerability.
Treatment-refractory vulvodynia from nutcracker syndrome: A case report.
Case Rep Womens Health
July 2018
The Pelvic Solutions Center, Denver, CO, United States.
Background: Pelvic venous disorders are often undiagnosed due to the symptom variability and similarity to other disease presentations. 'Pelvic congestion syndrome' is a term often used as a diagnosis of exclusion, since there is currently no standardized diagnostic approach for pelvic venous disorders, which further delays treatment.
Case: A 25-year-old woman with treatment-refractory vulvodynia presented with symptoms that included left-sided vaginal wall pain, pruritis, dysmenorrhea, dyspareunia, muscle tension, and a chronic vaginal ulceration.
Elevate and Uterine Preservation: Two-Year Results.
Female Pelvic Med Reconstr Surg
April 2016
From the *Oasis International Hospital, Beijing, China; †Atlanta Urogynecology, Atlanta, GA; ‡Academic Medical Center University of Amsterdam, Amsterdam, Netherlands; §Female Pelvic Medicine & Urogynecology Institute of Michigan, Grand Rapids, MI; ∥South Carolina OB/GYN, Columbia, SC; ¶The Pelvic Solutions Center, Denver, CO; **Hospital Clinic i Provincial de Barcelona, Universidad de Barcelona, Barcelona, Spain; and ††University of Washington Medical Center, Seattle, WA.
Objective: To evaluate efficacy of the Elevate Anterior and Apical (EAA) in the repair of pelvic organ prolapse (POP) when performed after previous hysterectomy and with or without uterine preservation during POP surgery.
Materials And Methods: One hundred forty-two women with anterior vaginal prolapse and/or apical descent ≥ stage II were enrolled. The primary outcome was treatment failure defined as > stage II POP-Q during follow-up using the Last observed Failure Carried Forward method.